AI assistant
Ventas, Inc. — Director's Dealing 2012
Jan 4, 2012
30143_dirs_2012-01-04_976b36b2-fdcb-4f2f-a67f-b3d1d9ed8f0d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VENTAS INC (VTR)
CIK: 0000740260
Period of Report: 2011-12-31
Reporting Person: PASQUALE DOUGLAS M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-12-31 | Common Stock | F | 4054 | $55.13 | Disposed | 174755 | Direct |
| 2012-01-01 | Common Stock | A | 1028 | — | Acquired | 175783 | Direct |
| 2012-01-03 | Common Stock | S | 20000 | $56.1346 | Disposed | 155783 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-01-01 | Stock Option (Right to Buy) | $55.13 | A | 5000 | Acquired | 2022-01-01 | Common Stock (5000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4326 | Indirect |
Footnotes
F1: Represents shares withheld to pay the taxes on the vesting and settlement of restricted stock units granted by Nationwide Health Properties, Inc. ("NHP") on February 15, 2011 and assumed by the Issuer pursuant to the Agreement and Plan of Merger, dated February 27, 2011, by and among Ventas, Inc., Needles Acquisition LLC and NHP.
F2: Restricted stock granted by Issuer pursuant to the Ventas, Inc. 2006 Stock Plan for Directors (the "Stock Plan"). This restricted stock vests in two equal annual installments beginning on the first anniversary of the date of grant.
F3: On January 3, 2012, the Reporting Person transmitted to the Securities and Exchange Commission (the "SEC") a Form 144 covering the sale of the Issuer's common stock reported on Table 1. The price reported in column 4 is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $56.00 to $56.32, inclusive. Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).
F4: These shares are being sold pursuant to a written non-discretionary Rule 10b5-1(c) sales plan dated November 23, 2011.
F5: Stock options granted by Issuer pursuant to the Stock Plan.
F6: These options vest in two equal annual installments beginning on the date of grant.
F7: Represents total number of unexercised stock options held by the Reporting Person as of January 1, 2012.